A recent study validates that combining genetic and clinical data can predict the risk for pulmonary fibrosis in patients ...

Pulmonary fibrosis—also known in technical terms as idiopathic pulmonary fibrosis (IPF)—is a rare but life-threatening ...

Non-Cystic Fibrosis Bronchiectasis Treatment Market to Reach USD 3.5 Bn by 2035 at 5.8% CAGR, Driven by rising disease burden ...

Lung diseases are a major global health concern. Many conditions begin silently with subtle signs. Early detection of ...

The Pulmonary Fibrosis Foundation (PFF) today announced a new five-year strategic plan, The PFF is ME, a community-driven roadmap shaped by input from more than 350 people affected by pulmonary ...

United Therapeutics' stock surged after IPF trial results and what future pivotal trials could mean for investors. See here ...

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease marked by gradual scarring, limiting lung function. The exact cause is unknown, but it combines genetic and environmental factors.

Select your location to view local American Lung Association events and news near you.

Individuals in close proximity to care for interstitial lung disease (ILD) did not have significantly improved outcomes than those at a greater distance, based on data from more than 1600 individuals ...

Caleigh has struggled most of her life with a difficult lung disease, but she never lets it get the best of her.

Combining genetic features with clinical data improved the performance of a pulmonary fibrosis prediction score for people with rheumatoid arthritis. A new combined risk score that incorporates ...

In a study of nearly 1,000 consecutive patients treated for lung cancer at Northwestern Medicine, researchers discovered only ...